| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 4.80e-06 | 5 | 158 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 7.66e-05 | 11 | 158 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 1.66e-04 | 14 | 158 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.69e-04 | 4 | 158 | 2 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.69e-04 | 4 | 158 | 2 | GO:0047685 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51B MYH10 MYH11 SMC6 WRNIP1 MCM5 ABCA8 DHX9 ABCA5 HELZ DDX3Y SLC27A4 KIF22 DNAH11 | 3.83e-04 | 614 | 158 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.02e-04 | 20 | 158 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 6.13e-04 | 5 | 158 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | receptor signaling protein tyrosine kinase activator activity | 6.13e-04 | 5 | 158 | 2 | GO:0030298 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 6.13e-04 | 5 | 158 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 6.13e-04 | 5 | 158 | 2 | GO:0047894 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | RAD51B XRN2 POLR1A IARS1 THUMPD3 WRNIP1 MCM5 DHX9 TYW5 ZC3H12D HELZ DDX3Y VARS1 TGS1 | 6.23e-04 | 645 | 158 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 7.66e-04 | 23 | 158 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 7.66e-04 | 23 | 158 | 3 | GO:0017116 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 9.40e-04 | 55 | 158 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.11e-03 | 26 | 158 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 1.27e-03 | 7 | 158 | 2 | GO:0050294 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.34e-03 | 152 | 158 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.53e-03 | 29 | 158 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.76e-03 | 65 | 158 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | XRN2 POLR1A IARS1 THUMPD3 DHX9 TYW5 ZC3H12D DDX3Y VARS1 TGS1 | 1.83e-03 | 417 | 158 | 10 | GO:0140098 |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 4.36e-06 | 5 | 158 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.46e-05 | 20 | 158 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 2.40e-05 | 8 | 158 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.58e-05 | 9 | 158 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 5.09e-05 | 10 | 158 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | fourth ventricle development | 5.83e-05 | 2 | 158 | 2 | GO:0021592 | |
| GeneOntologyBiologicalProcess | ADP transport | 9.22e-05 | 12 | 158 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.19e-04 | 13 | 158 | 3 | GO:0033131 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.79e-05 | 21 | 160 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.40e-05 | 8 | 160 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.08e-05 | 10 | 160 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.51e-04 | 14 | 160 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.30e-04 | 18 | 160 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | USH2 complex | 3.46e-04 | 4 | 160 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.56e-04 | 20 | 160 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 8.56e-04 | 6 | 160 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 8.56e-04 | 6 | 160 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 8.56e-04 | 6 | 160 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 8.56e-04 | 6 | 160 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | secretory granule membrane | 1.00e-03 | 329 | 160 | 9 | GO:0030667 | |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 1.19e-03 | 7 | 160 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.58e-03 | 8 | 160 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.68e-03 | 223 | 160 | 7 | GO:0098862 | |
| Domain | Grip | 1.51e-06 | 11 | 157 | 4 | SM00755 | |
| Domain | GRIP | 1.51e-06 | 11 | 157 | 4 | PF01465 | |
| Domain | Ran_BP1 | 2.26e-06 | 12 | 157 | 4 | PF00638 | |
| Domain | RANBD1 | 2.26e-06 | 12 | 157 | 4 | PS50196 | |
| Domain | GRIP_dom | 2.26e-06 | 12 | 157 | 4 | IPR000237 | |
| Domain | GRIP | 2.26e-06 | 12 | 157 | 4 | PS50913 | |
| Domain | RanBD | 3.24e-06 | 13 | 157 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 3.24e-06 | 13 | 157 | 4 | IPR000156 | |
| Domain | Rab_bind | 1.99e-05 | 7 | 157 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.99e-05 | 7 | 157 | 3 | IPR032023 | |
| Domain | Copine | 4.72e-05 | 9 | 157 | 3 | PF07002 | |
| Domain | Copine | 4.72e-05 | 9 | 157 | 3 | IPR010734 | |
| Domain | - | 6.70e-05 | 10 | 157 | 3 | 1.10.220.60 | |
| Domain | EIF3C_N_dom | 7.02e-05 | 2 | 157 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 7.02e-05 | 2 | 157 | 2 | PF05470 | |
| Domain | EIF3C | 7.02e-05 | 2 | 157 | 2 | IPR027516 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.21e-04 | 12 | 157 | 3 | PS00239 | |
| Domain | Mit_uncoupling | 1.21e-04 | 12 | 157 | 3 | IPR002030 | |
| Domain | P-loop_NTPase | MPP1 RAD51B MYH10 MYH11 NWD1 SMC6 WRNIP1 CHST6 MCM5 NKIRAS2 ABCA8 DHX9 ABCA5 HELZ DDX3Y CTPS1 KIF22 DNAH11 | 2.83e-04 | 848 | 157 | 18 | IPR027417 |
| Domain | NIPSNAP | 4.17e-04 | 4 | 157 | 2 | IPR012577 | |
| Domain | NIPSNAP | 4.17e-04 | 4 | 157 | 2 | PF07978 | |
| Domain | VWFA | 6.38e-04 | 82 | 157 | 5 | PS50234 | |
| Domain | Myosin_S1_N | 6.91e-04 | 5 | 157 | 2 | IPR008989 | |
| Domain | VWA | 7.12e-04 | 84 | 157 | 5 | SM00327 | |
| Domain | TPR-like_helical_dom | 8.08e-04 | 233 | 157 | 8 | IPR011990 | |
| Domain | BTB_2 | 1.02e-03 | 53 | 157 | 4 | PF02214 | |
| Domain | T1-type_BTB | 1.02e-03 | 53 | 157 | 4 | IPR003131 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 1.03e-03 | 6 | 157 | 2 | IPR009008 | |
| Domain | Anticodon_1 | 1.03e-03 | 6 | 157 | 2 | PF08264 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 1.03e-03 | 6 | 157 | 2 | IPR013155 | |
| Domain | - | 1.03e-03 | 6 | 157 | 2 | 3.90.740.10 | |
| Domain | - | 1.24e-03 | 95 | 157 | 5 | 2.60.120.200 | |
| Domain | aa-tRNA-synth_Ia | 1.43e-03 | 7 | 157 | 2 | IPR002300 | |
| Domain | Dimeric_a/b-barrel | 1.43e-03 | 7 | 157 | 2 | IPR011008 | |
| Domain | tRNA-synt_1 | 1.43e-03 | 7 | 157 | 2 | PF00133 | |
| Domain | VWF_A | 1.49e-03 | 99 | 157 | 5 | IPR002035 | |
| Domain | - | MPP1 RAD51B NWD1 SMC6 WRNIP1 CHST6 MCM5 NKIRAS2 ABCA8 DHX9 ABCA5 HELZ DDX3Y CTPS1 DNAH11 | 1.58e-03 | 746 | 157 | 15 | 3.40.50.300 |
| Domain | Aden_trnslctor | 1.64e-03 | 28 | 157 | 3 | IPR002113 | |
| Domain | TPR-contain_dom | 1.70e-03 | 150 | 157 | 6 | IPR013026 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.97e-06 | 13 | 105 | 4 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.97e-06 | 13 | 105 | 4 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.21e-06 | 18 | 105 | 4 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.03e-05 | 19 | 105 | 4 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.28e-05 | 20 | 105 | 4 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.58e-05 | 21 | 105 | 4 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.92e-05 | 22 | 105 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.92e-05 | 22 | 105 | 4 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.31e-05 | 23 | 105 | 4 | M47676 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 4.64e-05 | 10 | 105 | 3 | M47694 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 8.41e-05 | 12 | 105 | 3 | M27728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.09e-04 | 13 | 105 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.38e-04 | 14 | 105 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.71e-04 | 15 | 105 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.10e-04 | 16 | 105 | 3 | M47695 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 2.87e-04 | 43 | 105 | 4 | M881 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.02e-04 | 18 | 105 | 3 | MM1549 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 3.02e-04 | 18 | 105 | 3 | M47761 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | CHL1 EPHB6 SEMA4D COL6A3 MYH10 MYH11 ANK2 TUBB8 CNTNAP1 ADGRV1 GFRA1 PLXNA4 TUBB8B | 3.37e-04 | 575 | 105 | 13 | M29853 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 3.57e-04 | 19 | 105 | 3 | M47677 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 4.17e-04 | 20 | 105 | 3 | M18415 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 5.42e-04 | 5 | 105 | 2 | M47807 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 6.38e-04 | 23 | 105 | 3 | M47666 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 7.25e-04 | 24 | 105 | 3 | M2243 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 9.05e-04 | 58 | 105 | 4 | MM14736 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 9.86e-04 | 153 | 105 | 6 | MM15844 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 MYH10 RGPD8 SLC25A4 SLC25A5 IARS1 UBR4 WRNIP1 MCM5 HUWE1 RCC2 EIF3CL DHX9 FXR1 CDK13 RGPD3 DDX3Y EIF3C CTPS1 VARS1 | 4.29e-11 | 665 | 161 | 20 | 30457570 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 RGPD4 XRN2 POLR1A RGPD8 SLC25A4 SLC25A5 SLC25A6 IARS1 UBR4 WRNIP1 MCM5 HUWE1 RCC2 NDUFS3 EIF3CL DHX9 FXR1 TELO2 RGPD3 DDX3Y EIF3C CTPS1 VARS1 SLC27A4 RGPD5 | 1.63e-10 | 1257 | 161 | 26 | 37317656 |
| Pubmed | RGPD4 CPNE8 XRN2 CPNE9 RGPD8 SLC25A4 SLC25A5 SLC25A6 TRAPPC5 UBR4 DUT MCM5 RCC2 EIF3CL DHX9 SERPINB6 RGPD3 DDX3Y EIF3C CTPS1 RGPD5 | 4.31e-10 | 844 | 161 | 21 | 25963833 | |
| Pubmed | MON2 RGPD4 MYH10 ANK2 RGPD8 SLC25A5 IARS1 UBR4 CNTNAP1 WRNIP1 KCNAB2 HUWE1 NDUFS3 EIF3CL PTK7 ITPR1 SERPINB6 RABGAP1L RGPD3 HELZ TNFAIP1 EIF3C VARS1 CEP170B | 6.20e-10 | 1139 | 161 | 24 | 36417873 | |
| Pubmed | XRN2 MYH10 DNAJC13 SLC25A5 IARS1 UBR4 WRNIP1 MCM5 HUWE1 RCC2 FAM83H DHX9 CRNKL1 FXR1 TELO2 EIF3C CTPS1 VARS1 | 1.18e-09 | 638 | 161 | 18 | 33239621 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MPP1 XRN2 MYH10 POLR1A SLC25A4 SLC25A5 SLC25A6 IARS1 UBR4 MCM5 HUWE1 GRSF1 NDUFS3 FAM83H EIF3CL DHX9 CRNKL1 FXR1 HELZ DDX3Y CTPS1 TUBB8B VARS1 TENT2 KIF22 | 2.23e-09 | 1318 | 161 | 25 | 30463901 |
| Pubmed | RGPD4 RAD51B MAP9 MYH10 MYH11 ANK2 RGPD8 SLC25A4 SLC25A5 SLC25A6 TRAPPC5 ECD UBR4 MCM5 PTPN21 NKIRAS2 FER1L6 PTK7 FXR1 CDK13 RGPD3 PLXNA4 PCDHGC3 VARS1 SLC27A4 RGPD5 | 2.94e-09 | 1442 | 161 | 26 | 35575683 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.53e-08 | 7 | 161 | 4 | 15710750 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | XRN2 MYH10 MYH11 POLR1A SLC25A5 SLC25A6 IARS1 MCM5 RCC2 EIF3CL ITPR1 DHX9 CRNKL1 FXR1 CDK13 DDX3Y EIF3C CTPS1 VARS1 KIF22 | 1.88e-08 | 949 | 161 | 20 | 36574265 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 4.40e-08 | 153 | 161 | 9 | 26365490 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | SLC25A5 IARS1 ECD THUMPD3 MRPL43 WRNIP1 MCM5 HUWE1 GRSF1 NDUFS3 KLHL11 TELO2 CTPS1 VARS1 RGPD5 | 7.75e-08 | 571 | 161 | 15 | 37167062 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 MAP9 TRAPPC5 PIGS CDS2 MRPL43 FXR1 TELO2 JRK VPS35L NKX2-5 EIF3C FASTKD3 YIPF3 ALDH7A1 SLC27A4 TGS1 | 9.11e-08 | 754 | 161 | 17 | 33060197 |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 9.74e-08 | 3 | 161 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 9.74e-08 | 3 | 161 | 3 | 2829183 | |
| Pubmed | Biochemical characterization of copine: a ubiquitous Ca2+-dependent, phospholipid-binding protein. | 9.74e-08 | 3 | 161 | 3 | 11123945 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 URI1 SLC25A4 SLC25A5 SLC25A6 TUBB8 IARS1 ECD UBR4 DUT MCM5 HUWE1 GRSF1 RCC2 NDUFS3 DHX9 CRNKL1 SERPINB6 FXR1 CDK13 EIF3C CTPS1 VARS1 | 1.71e-07 | 1415 | 161 | 23 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | XRN2 MYH10 POLR1A SLC25A5 IARS1 UBR4 SMC6 THUMPD3 DUT MCM5 NIPSNAP3A HUWE1 GRSF1 RCC2 NDUFS3 EIF3CL DHX9 CRNKL1 FXR1 EIF3C CTPS1 VARS1 SLC27A4 | 1.94e-07 | 1425 | 161 | 23 | 30948266 |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.95e-07 | 182 | 161 | 9 | 32239614 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | XRN2 POLR1A SLC25A4 SLC25A5 SLC25A6 UBR4 THUMPD3 MCM5 HUWE1 NDUFS3 DHX9 FXR1 RGPD3 DDX3Y EIF3C CTPS1 | 2.00e-07 | 704 | 161 | 16 | 29955894 |
| Pubmed | MAP9 MYH10 MYH11 DNAJC13 ANK2 SLC25A4 SLC25A5 IARS1 CNTNAP1 WRNIP1 KCNAB2 NDUFS3 EIF3CL DHX9 FXR1 PLXNA4 DDX3Y EIF3C PCDH1 VARS1 CEP170B ALDH7A1 DNAH11 | 2.08e-07 | 1431 | 161 | 23 | 37142655 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.06e-07 | 13 | 161 | 4 | 31427429 | |
| Pubmed | 3.80e-07 | 197 | 161 | 9 | 31620119 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 33396658 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYH10 SLC25A5 IARS1 ECD WRNIP1 MCM5 HUWE1 DHX9 CRNKL1 FXR1 EIF3C CTPS1 VARS1 | 3.91e-07 | 477 | 161 | 13 | 31300519 |
| Pubmed | MON2 CHST14 IARS1 PIGS CDS2 UBR4 WRNIP1 HUWE1 NDUFS3 DHX9 TELO2 CPNE1 CTPS1 YIPF3 SLC27A4 | 4.63e-07 | 657 | 161 | 15 | 36180527 | |
| Pubmed | 4.69e-07 | 202 | 161 | 9 | 24639526 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | XRN2 MYH10 SLC25A5 SLC25A6 HUWE1 GRSF1 DHX9 FXR1 TELO2 AP5B1 | 4.76e-07 | 264 | 161 | 10 | 32814769 |
| Pubmed | MPP1 PPP1R21 XRN2 DNAJC13 SLC25A5 IARS1 PIGS CDS2 UBR4 WRNIP1 MCM5 HUWE1 PARP14 ITPR1 DHX9 FXR1 HELZ DDX3Y CTPS1 SLC27A4 | 5.26e-07 | 1168 | 161 | 20 | 19946888 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MPP1 MYH10 SLC25A5 IARS1 UBR4 KCNAB2 HUWE1 ITGAM EIF3CL EIF3C VARS1 | 6.72e-07 | 344 | 161 | 11 | 30333137 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 URI1 DYNC2I2 TPTE2 ECD UBR4 WRNIP1 MCM5 HUWE1 PTPN21 RCC2 PTK7 FXR1 TELO2 HELZ EIF3C VARS1 SLC27A4 | 6.90e-07 | 974 | 161 | 18 | 28675297 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | XRN2 MYH10 DNAJC13 POLR1A SLC25A5 IARS1 UBR4 THUMPD3 MCM5 HUWE1 GRSF1 NDUFS3 FAM83H DHX9 CRNKL1 SERPINB6 FXR1 CTPS1 VARS1 ALDH7A1 SLC27A4 | 1.29e-06 | 1353 | 161 | 21 | 29467282 |
| Pubmed | XRN2 MYH11 SLC25A4 SLC25A5 SLC25A6 TUBB8 IARS1 DUT MCM5 GRSF1 NDUFS3 DHX9 CDK13 RABGAP1L DDX3Y EIF3C TUBB8B VARS1 TGS1 | 1.82e-06 | 1153 | 161 | 19 | 29845934 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 10620603 | ||
| Pubmed | URI1 DYNC2I2 NIPSNAP3B IARS1 NIPSNAP3A NKIRAS2 EIF3CL EIF3C TGS1 | 2.32e-06 | 245 | 161 | 9 | 19521500 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYH10 POLR1A SLC25A5 SLC25A6 IARS1 MCM5 NDUFS3 DHX9 FXR1 TELO2 DDX3Y CTPS1 SLC27A4 | 2.56e-06 | 565 | 161 | 13 | 33567341 |
| Pubmed | 2.80e-06 | 187 | 161 | 8 | 26460568 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | XRN2 SLC25A4 SLC25A5 SLC25A6 IARS1 HUWE1 GRSF1 RCC2 DHX9 FXR1 CTPS1 SLC27A4 | 3.08e-06 | 486 | 161 | 12 | 30940648 |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 9037092 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 21370995 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.36e-06 | 7 | 161 | 3 | 11353387 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 30944974 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.36e-06 | 7 | 161 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.36e-06 | 7 | 161 | 3 | 17372272 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 38657106 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 21205196 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 18949001 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 25187515 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 8603673 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 26632511 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 24403063 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 23818861 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 9889000 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 23536549 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 12191015 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 22821000 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 20682751 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | XRN2 MYH10 MYH11 SLC25A5 SLC25A6 IARS1 MCM5 GRSF1 RCC2 EIF3CL DHX9 CPNE1 EPS8L3 | 3.40e-06 | 580 | 161 | 13 | 35676659 |
| Pubmed | MON2 CPNE8 XRN2 MYH10 SLC25A6 TUBB8 TRAPPC5 PIGS ECD UBR4 DUT MRPL43 MCM5 HUWE1 RCC2 ITPR1 TELO2 VPS35L EIF3C CTPS1 SLC27A4 | 3.43e-06 | 1440 | 161 | 21 | 30833792 | |
| Pubmed | XRN2 URI1 SLC25A4 SLC25A5 SLC25A6 IARS1 TRAPPC5 THUMPD3 DUT MRPL43 MCM5 HUWE1 RCC2 NDUFS3 DHX9 FXR1 DDX3Y EIF3C CTPS1 ALDH7A1 | 4.02e-06 | 1335 | 161 | 20 | 29229926 | |
| Pubmed | 4.43e-06 | 199 | 161 | 8 | 23382691 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.95e-06 | 202 | 161 | 8 | 33005030 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.36e-06 | 8 | 161 | 3 | 21670213 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 27641616 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.36e-06 | 8 | 161 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.36e-06 | 8 | 161 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.36e-06 | 8 | 161 | 3 | 28745977 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CPNE8 XRN2 POLR1A SLC25A5 SLC25A6 IARS1 MCM5 HUWE1 RCC2 NDUFS3 FAM83H DHX9 CRNKL1 FXR1 EIF3C VARS1 KIF22 | 5.97e-06 | 1024 | 161 | 17 | 24711643 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | XRN2 MYH11 SLC25A4 SLC25A5 SLC25A6 IARS1 MCM5 NDUFS3 DHX9 CRNKL1 FXR1 EIF3C CTPS1 VARS1 | 6.55e-06 | 714 | 161 | 14 | 28302793 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD8 DYNC2I2 SLC25A4 ECD SMC6 MRPL43 FAM83H EIF3CL ITPR1 DHX9 CRNKL1 KANK1 RGPD3 EIF3C CEP170B RGPD5 TGS1 | 7.42e-06 | 1155 | 161 | 18 | 20360068 |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 9430674 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 8.01e-06 | 9 | 161 | 3 | 18394993 | |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 28100513 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 17887960 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 21292980 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 11553612 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 10601307 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 9733766 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 28877029 | ||
| Pubmed | MON2 MPP1 POLR1A RGPD8 WRNIP1 HUWE1 KANK1 FXR1 HELZ CTPS1 VARS1 YIPF3 SLC27A4 TGS1 | 8.80e-06 | 733 | 161 | 14 | 34672954 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CHL1 MON2 COL6A3 CPNE8 MYH10 MYH11 CPNE9 TUBB8 CPE ITGAM PGAP6 SERPINB6 ST3GAL6 CPNE1 TNXB TUBB8B ALDH7A1 | 1.06e-05 | 1070 | 161 | 17 | 23533145 |
| Pubmed | XRN2 MYH10 PRMT8 SLC25A5 IARS1 UBR4 MCM5 HUWE1 DHX9 CRNKL1 FXR1 EIF3C | 1.09e-05 | 551 | 161 | 12 | 34728620 | |
| Pubmed | LTK and ALK promote neuronal polarity and cortical migration by inhibiting IGF1R activity. | 1.14e-05 | 10 | 161 | 3 | 37291945 | |
| Pubmed | 1.14e-05 | 10 | 161 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.14e-05 | 10 | 161 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.14e-05 | 10 | 161 | 3 | 8857542 | |
| Pubmed | 1.14e-05 | 10 | 161 | 3 | 21859863 | ||
| Pubmed | 1.22e-05 | 64 | 161 | 5 | 22865885 | ||
| Pubmed | 1.44e-05 | 234 | 161 | 8 | 36243803 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.49e-05 | 235 | 161 | 8 | 30258100 | |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.56e-05 | 11 | 161 | 3 | 35771867 | |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 34110283 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.84e-05 | 175 | 161 | 7 | 25756610 | |
| Pubmed | 1.90e-05 | 70 | 161 | 5 | 34255829 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | SATB2 XRN2 DYNC2I2 SLC25A5 SLC25A6 WRNIP1 HUWE1 RCC2 DHX9 NKX2-5 EIF3C CTPS1 | 1.90e-05 | 583 | 161 | 12 | 29844126 |
| Pubmed | 2.08e-05 | 12 | 161 | 3 | 16120388 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 18790697 | ||
| Interaction | PPP5C interactions | ABHD14A MYH10 MYH11 PRMT8 DUT HUWE1 DHX9 CDK13 RABGAP1L CPNE1 CTPS1 | 1.16e-05 | 272 | 160 | 11 | int:PPP5C |
| Interaction | C9orf72 interactions | MON2 RGPD4 XRN2 POLR1A RGPD8 SLC25A4 SLC25A5 SLC25A6 IARS1 UBR4 WRNIP1 MCM5 HUWE1 RCC2 NDUFS3 EIF3CL DHX9 FXR1 TELO2 RGPD3 DDX3Y EIF3C CTPS1 VARS1 SLC27A4 RGPD5 | 1.52e-05 | 1319 | 160 | 26 | int:C9orf72 |
| Interaction | KDF1 interactions | 2.34e-05 | 192 | 160 | 9 | int:KDF1 | |
| Interaction | RGPD4 interactions | 2.50e-05 | 22 | 160 | 4 | int:RGPD4 | |
| Interaction | CCNJL interactions | 2.80e-05 | 45 | 160 | 5 | int:CCNJL | |
| GeneFamily | Copines | 1.84e-05 | 9 | 111 | 3 | 829 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.22e-04 | 4 | 111 | 2 | 1244 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-07 | 172 | 161 | 8 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-07 | 186 | 161 | 8 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-07 | 186 | 161 | 8 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-07 | 186 | 161 | 8 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.02e-07 | 186 | 161 | 8 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.02e-07 | 186 | 161 | 8 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.02e-07 | 186 | 161 | 8 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-07 | 186 | 161 | 8 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-07 | 186 | 161 | 8 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 4.02e-07 | 186 | 161 | 8 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 4.36e-07 | 188 | 161 | 8 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 4.36e-07 | 188 | 161 | 8 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.11e-07 | 192 | 161 | 8 | 56f2388c9c4e19883ae5cff332c77f596ff744a8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-07 | 195 | 161 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-07 | 197 | 161 | 8 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-07 | 197 | 161 | 8 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.70e-07 | 199 | 161 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.70e-07 | 199 | 161 | 8 | b877c1d24357249781032e99d4237f72789cc9b8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.70e-07 | 199 | 161 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.70e-07 | 199 | 161 | 8 | e32fa66f3361474088ba1dd58574822537950d59 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.95e-07 | 200 | 161 | 8 | 28e5354008adf97b17333f17f8cbef930db6729a | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.95e-07 | 200 | 161 | 8 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | 6.95e-07 | 200 | 161 | 8 | 803cf7f1382d07220249029cd220233232027689 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.95e-07 | 200 | 161 | 8 | 56536236a7012efdb28f85b40e464f3da3e87ce8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.99e-06 | 57 | 161 | 5 | 5ae53d915bee8a5fc7936d2a46517da1b6abbf79 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2-Inhibitory_Gad1Gad2_Htr3a.Chrm2_(Interneuron,__(candidate_CGE-derived_10))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.99e-06 | 57 | 161 | 5 | e61b10212685e5217550db0812141a1f3f6567c8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Chrm2-Inhibitory_Gad1Gad2_Htr3a.Chrm2_(Interneuron,__(candidate_CGE-derived_10))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.99e-06 | 57 | 161 | 5 | f5edb5e8eddc51e0b8040e88baa5d8971871f9ea | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 2.02e-06 | 161 | 161 | 7 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.48e-06 | 166 | 161 | 7 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.58e-06 | 167 | 161 | 7 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.69e-06 | 168 | 161 | 7 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 176 | 161 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 176 | 161 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-06 | 177 | 161 | 7 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.39e-06 | 181 | 161 | 7 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.39e-06 | 181 | 161 | 7 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 4.39e-06 | 181 | 161 | 7 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.39e-06 | 181 | 161 | 7 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-06 | 182 | 161 | 7 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.56e-06 | 182 | 161 | 7 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-06 | 182 | 161 | 7 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-06 | 183 | 161 | 7 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.07e-06 | 185 | 161 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.07e-06 | 185 | 161 | 7 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.07e-06 | 185 | 161 | 7 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.07e-06 | 185 | 161 | 7 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.07e-06 | 185 | 161 | 7 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.44e-06 | 187 | 161 | 7 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 5.44e-06 | 187 | 161 | 7 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.64e-06 | 188 | 161 | 7 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.64e-06 | 188 | 161 | 7 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 5.64e-06 | 188 | 161 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.64e-06 | 188 | 161 | 7 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.64e-06 | 188 | 161 | 7 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.64e-06 | 188 | 161 | 7 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.84e-06 | 189 | 161 | 7 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.84e-06 | 189 | 161 | 7 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 5.84e-06 | 189 | 161 | 7 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.84e-06 | 189 | 161 | 7 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.04e-06 | 190 | 161 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 6.25e-06 | 191 | 161 | 7 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 6.25e-06 | 191 | 161 | 7 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-06 | 192 | 161 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 6.47e-06 | 192 | 161 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-06 | 193 | 161 | 7 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-06 | 193 | 161 | 7 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-06 | 193 | 161 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.92e-06 | 194 | 161 | 7 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-06 | 194 | 161 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-06 | 194 | 161 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-06 | 195 | 161 | 7 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.16e-06 | 195 | 161 | 7 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-06 | 195 | 161 | 7 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.16e-06 | 195 | 161 | 7 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 7.16e-06 | 195 | 161 | 7 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.16e-06 | 195 | 161 | 7 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-06 | 195 | 161 | 7 | 359b9d791e26844675c3c60cf69d8ab69c2cf400 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.40e-06 | 196 | 161 | 7 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.40e-06 | 196 | 161 | 7 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.40e-06 | 196 | 161 | 7 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.65e-06 | 197 | 161 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.65e-06 | 197 | 161 | 7 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-pDC|Influenza_Severe / Disease, condition lineage and cell class | 7.65e-06 | 197 | 161 | 7 | e8e6f71e6dc8a695e4321a18543c1df63dd62f3e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 197 | 161 | 7 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-06 | 197 | 161 | 7 | 1018aac22659c081d227d566afa29b1748c18ade | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.65e-06 | 197 | 161 | 7 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 198 | 161 | 7 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 7.91e-06 | 198 | 161 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 198 | 161 | 7 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 198 | 161 | 7 | 5b9a7b9f53a3d9cf8d6e6a7c1c94514b22cf9fa8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 198 | 161 | 7 | 5c96778cf5623c662c2259fe70f8665c14a161dd | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 7.91e-06 | 198 | 161 | 7 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-06 | 198 | 161 | 7 | 6e314dc820db9c53fe7fc7c96bed4d7d9a325160 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-06 | 198 | 161 | 7 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 8.17e-06 | 199 | 161 | 7 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| Drug | Clodronate | 3.34e-07 | 3 | 159 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 1.33e-06 | 4 | 159 | 3 | ctd:C000600819 | |
| Disease | epilepsy (implicated_via_orthology) | 1.73e-07 | 163 | 151 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 5.24e-07 | 4 | 151 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 3.05e-05 | 35 | 151 | 4 | DOID:700 (implicated_via_orthology) | |
| Disease | neuroblastoma (implicated_via_orthology) | 2.58e-04 | 5 | 151 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | MON2 CPNE8 CLSTN3 GFRA1 CNTNAP5 AP5B1 DERL3 USH2A CEP170B TENT2 | 3.79e-04 | 523 | 151 | 10 | EFO_0005193 |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 4.35e-04 | 29 | 151 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 7.14e-04 | 8 | 151 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | gdnf family receptor alpha-1 measurement | 7.14e-04 | 8 | 151 | 2 | EFO_0020400 | |
| Disease | Colorectal Carcinoma | CHL1 EPHB6 CPAMD8 CLSTN3 SATB2 ANK2 FSTL5 CPE ABCA8 FBLN2 ABCA5 | 1.01e-03 | 702 | 151 | 11 | C0009402 |
| Disease | descending aortic diameter | 1.10e-03 | 88 | 151 | 4 | EFO_0021788 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 1.14e-03 | 10 | 151 | 2 | DOID:7693 (is_marker_for) | |
| Disease | ptosis (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0090132 (implicated_via_orthology) | |
| Disease | gastric carcinoma | 1.15e-03 | 89 | 151 | 4 | EFO_0000178 | |
| Disease | urate measurement, bone density | FSTL5 ABCA8 ITPR1 CNTNAP5 RABGAP1L USP40 PLXNA4 USH2A TNXB DNAH11 | 1.37e-03 | 619 | 151 | 10 | EFO_0003923, EFO_0004531 |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.66e-03 | 12 | 151 | 2 | DOID:0050997 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.66e-03 | 12 | 151 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.81e-03 | 47 | 151 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | Ciliopathies | 2.50e-03 | 110 | 151 | 4 | C4277690 | |
| Disease | infant grey matter volume measurement | 3.77e-03 | 18 | 151 | 2 | EFO_0008368 | |
| Disease | X-11470 measurement | 4.20e-03 | 19 | 151 | 2 | EFO_0021241 | |
| Disease | Ewing sarcoma | 4.65e-03 | 20 | 151 | 2 | EFO_0000174 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEVDRLQREIQYIFP | 1541 | Q8WWZ7 | |
| VRDRVDIQSAYPFQI | 386 | Q6UXC1 | |
| APVEAALDELQRRIY | 516 | Q86VI1 | |
| VYPLDFARTRLAADV | 131 | P12236 | |
| PYVRVELNTSRDVVF | 836 | P78357 | |
| FAPVFVERLYRAAVT | 141 | Q9BQT9 | |
| RLFEDYNEIIRPVAN | 41 | P32297 | |
| FPEARIYEETLNVLL | 241 | Q13829 | |
| PIARVRQASVADYEE | 76 | P49419 | |
| DDPIYFAEPRVVRVQ | 1001 | Q8WXG9 | |
| NEVLYRIYAAEPRII | 5836 | Q8WXG9 | |
| VYPLDFARTRLAADV | 131 | P05141 | |
| TDYFFTLVQREEPLR | 146 | O95674 | |
| RPVAARASLLYFVIN | 3706 | Q96DT5 | |
| TYAYLENRVRPLVLV | 296 | Q6PIY7 | |
| YVQILEIVRDVYVAP | 581 | Q008S8 | |
| PDRAALYVVAIEDRQ | 216 | Q9NR22 | |
| YVLERVQHRVPEEAL | 96 | Q9Y4F5 | |
| LAAEFLQVPAVTRAY | 6 | Q96Q80 | |
| YRRKLREEFVFIPAA | 956 | Q14004 | |
| RLVAAAVQAFYLRDP | 226 | O95905 | |
| AVQAFYLRDPIDLRA | 231 | O95905 | |
| ARPSDLELVARYFQR | 96 | Q149M9 | |
| RLVEIAESRFPRYFN | 151 | O15315 | |
| IEYDCELVPRRVAIF | 301 | Q9P258 | |
| DPRVVAAVRESVNYL | 216 | Q9UFN0 | |
| RPDDVHVNIRLVELY | 161 | Q99666 | |
| RPDDVHVNIRLVELY | 161 | O14715 | |
| REEIGNRYIEIFPSR | 311 | Q12849 | |
| IFYREVLPLNQAHRV | 81 | Q9BUJ0 | |
| RIITRDFPQYFAVVS | 1141 | Q01484 | |
| VYVAAPALVEELLRQ | 86 | O15528 | |
| PFDRLVVVYTFLAVL | 226 | A6NDP7 | |
| IEPDRADNIRAAVYQ | 416 | Q49MG5 | |
| RREADFYQVQPLIEA | 81 | Q4G0X4 | |
| LAPFVRYQFRVIAVN | 676 | O00533 | |
| EFRRLAALPNVYEVI | 321 | P33992 | |
| VEEYLRDVVCQRFPF | 841 | Q14643 | |
| ATYNEIVTFERLRPV | 101 | P51114 | |
| PFSEEQARLYLRDVI | 246 | Q8N5S9 | |
| DRTLPLVEEIDQRYF | 181 | Q9BVA6 | |
| ATDYDVRVLLRFPQR | 411 | Q08397 | |
| SQYDIPRLAAFLRRV | 101 | Q96EX3 | |
| LRHLIEIPVRYQEEF | 6 | Q12988 | |
| YVFRVRAGELEPLLV | 216 | P29376 | |
| VVYLQRAVLEPRDFA | 1141 | P98095 | |
| DLVFQYVEDPTIVRI | 1031 | Q9HCM2 | |
| AVAFDAVLRFAERQP | 491 | O75564 | |
| RPALDSLIRDVVQAY | 71 | Q96T54 | |
| EYTFHQAPEVVRRLL | 316 | Q08174 | |
| LIANIAPERRFYLDT | 341 | Q14807 | |
| QVLYEFEARNPRELT | 456 | Q8TE67 | |
| DPRVVAAVRESVNYL | 216 | Q9BS92 | |
| VADRRSLLEPFVYLA | 151 | Q9NYR9 | |
| AAFEAISPDVLRYVI | 1141 | Q14678 | |
| YVFFRPTIQVELEQE | 121 | Q8N4P6 | |
| RFRVEGQLYAPLEAV | 696 | Q2VPB7 | |
| AYVFQPELLVTRVVE | 176 | Q9HCN3 | |
| YVPFAERSLEVVVDL | 1406 | Q7Z3U7 | |
| DRFVAIVHPQRYLVL | 121 | O60431 | |
| APVFNQSLYRARVLE | 241 | Q9UN70 | |
| DDPFQIYRAELRVRD | 111 | Q9UN67 | |
| LESVPYEEALANRRI | 536 | Q6ZMI0 | |
| RIAQLICERIFYPEI | 216 | P33316 | |
| GVVTPYADQVFRIRA | 951 | P42694 | |
| PFAVLVDYIRVLDFD | 3981 | Q7Z6Z7 | |
| PRVLFSQAQVYELER | 141 | P52952 | |
| VDRFVAVAVPLRYNR | 131 | P21917 | |
| RLQLEYVDVVFANRP | 146 | Q13303 | |
| VRFLLETVVRVYPAN | 406 | Q5R372 | |
| EEFYRAFQVIQLSLP | 236 | Q8N475 | |
| RFQDVLPYDDVRVEL | 926 | Q16825 | |
| VFFYPEDVRQKVLER | 56 | Q460N5 | |
| RPDDVHVNIRLVELY | 161 | A6NKT7 | |
| GVPRFYIRILADLED | 101 | Q99613 | |
| GVPRFYIRILADLED | 101 | B5ME19 | |
| IDRARAIYELAISQP | 656 | Q9BZJ0 | |
| DRFVYIAARTPVDRD | 501 | Q9NVR0 | |
| NVPLDIFLEEIRFYQ | 111 | P17658 | |
| YVQREALRVPLIFRE | 96 | Q8NHM5 | |
| YEPVNSRLSDIFRVV | 121 | P56159 | |
| FQYVQRPLRLTRFDV | 961 | Q8IZJ3 | |
| PEFQYVRTLIERLVD | 1246 | P12111 | |
| RLVFTVREFRELPNI | 1591 | P12111 | |
| AERDIVQFVPFRDYV | 486 | Q8IYJ1 | |
| DLNRNFPDLDRIVYV | 186 | P16870 | |
| IFVRVYNEVPTFQLE | 1691 | O75165 | |
| LDVVSYEEVVRLPAF | 266 | Q00013 | |
| YRNEEVPINDAVVFR | 76 | Q49AJ0 | |
| APTRELAVQIYEEAR | 271 | O15523 | |
| EVLEAAARRVPVYIL | 166 | Q6ZRV2 | |
| YLRQLEEEGITFVPR | 166 | Q92503 | |
| RALPVFYAATIAINV | 181 | Q08357 | |
| AERDIVQFVPFRDYI | 496 | Q86YQ8 | |
| PNRIVFQEFRQRYEI | 716 | P35580 | |
| PVALNVQYAPRDVRV | 496 | P20273 | |
| RLSYNFSPEVEFRVI | 1121 | Q8WYK1 | |
| AARDIVQFVPYRRFQ | 476 | Q99829 | |
| DFLLVVLRDVVQAYP | 521 | Q08211 | |
| SVLPEREVEEFLYRA | 231 | Q8N344 | |
| AVPDELLTLYFENRR | 21 | Q53GL7 | |
| DDPFQIYRAELRVRD | 111 | Q9Y5E1 | |
| DIEGAVRRYVQPFLN | 246 | Q96S52 | |
| ADFYQIRPLLDALRE | 61 | Q693B1 | |
| VLIRVYIVAAFNLSP | 1356 | Q2WGJ9 | |
| RQPEFRAVLGEVVLY | 196 | P26640 | |
| FIYRRPAGIEEESVL | 3901 | O75445 | |
| RPDDVHVNIRLVELY | 161 | Q7Z3J3 | |
| VIDFARRNPGVVIYV | 51 | Q8N983 | |
| RVQAVREIHPFIDDY | 1501 | O95602 | |
| RTPADIYRAFVDVVN | 386 | O94763 | |
| VFYVIETREPRERLL | 251 | Q15465 | |
| LQARVEPFFIYRART | 66 | Q14DG7 | |
| QAFPARERIGSVVVY | 251 | Q14DG7 | |
| IVRILFIVPIYAFDS | 81 | Q9Y519 | |
| FTPEDIVALYRILQA | 251 | Q14CZ7 | |
| AVDVPTRQNRFEIVY | 116 | O75489 | |
| QAIRELAREVDPAYI | 656 | O15197 | |
| YQERVFLFVDPELVS | 151 | Q5UE93 | |
| IVLLAIYVPDIRNVF | 381 | Q8IZM9 | |
| FLNLPEVERDRIYQD | 421 | Q9UPW6 | |
| DPLTRLVLVNAVYFR | 156 | P35237 | |
| GVVDYFLRRLDLPIE | 261 | P17812 | |
| IRILDPFIIRTAAYE | 226 | Q9Y274 | |
| PQNYFRLLGEEVVRV | 181 | Q9Y4R8 | |
| RYVFEDPDVVALVVR | 101 | A0A087WV53 | |
| ECIYILEAAPRQRIE | 71 | Q8NC67 | |
| YLINSPVVRAENLRF | 626 | P41252 | |
| EYEFVFRVLIPRIAR | 241 | Q92854 | |
| VIPEADREGVIRYVI | 271 | P11215 | |
| NRAPIYVRVPFLEVN | 71 | P0DMN0 | |
| NRAPIYVRVPFLEVN | 71 | P0DMM9 | |
| EILRLFPQAARQERY | 1531 | O94911 | |
| QVLLPEYLRERFVAA | 261 | Q9C0B6 | |
| VDFVVPSLFRVYARD | 56 | Q9UM73 | |
| EDRPNFAIILERIEY | 1371 | Q9UM73 | |
| VFVDQRATAILAYLP | 351 | O00327 | |
| VYPLDFARTRLAADV | 131 | P12235 | |
| LAREPLAEIRALYAF | 276 | Q9GZX3 | |
| FVREPLERLLSAYRN | 211 | Q8NCH0 | |
| PNRIVFQEFRQRYEI | 716 | P35749 | |
| LVVTAYAIPREARVN | 136 | Q9NUR3 | |
| SIRELIPRFYVEASI | 286 | Q7Z3J2 | |
| REEYPDRIINTFSIL | 156 | Q3ZCM7 | |
| SFVYPIRLVRVNEDT | 411 | Q6P1M0 | |
| VLEQFLTILPREFYA | 86 | Q6NSZ9 | |
| IFEYIDRLFSIVRPR | 81 | Q9H0D6 | |
| LRPQAEVDRFVVSYV | 861 | P22105 | |
| REEYPDRIINTFSIL | 156 | A6NNZ2 | |
| VIHIVDQRVRFYPVA | 131 | Q8NCL8 | |
| PIIVSEFRNEIYDVR | 561 | Q96SB8 | |
| ARIALYSVFPRDQVD | 481 | A2A288 | |
| LPVVFEDVAVYFTRE | 331 | O60290 | |
| RAAVYVLIRTPQAFV | 476 | Q9BV44 | |
| VRRDSEVVLLFFYAP | 121 | Q6PKC3 | |
| DPLYVARRLVRFASE | 531 | Q96S55 | |
| YFDVEPAQVRSRLLE | 121 | Q9GZM5 | |
| FYRNPIEEVVRFLDK | 241 | Q6XPS3 | |
| IVYFLPRNADIDQVA | 801 | Q96RS0 | |
| VALTPEEREQRALYA | 226 | Q9Y2B5 | |
| NLDDYRTPVFIFERL | 4321 | Q5T4S7 | |
| RVVLAPQDVVVARYE | 226 | Q13308 | |
| SLRQRVADFYRLPVE | 1101 | Q9NVE5 | |
| RFRYQEAASPREALI | 51 | O95125 | |
| PDVEEVNLYRIFNRV | 756 | Q6ZT98 | |
| VYRTLPFDQLVQRAA | 76 | A2RUC4 | |
| DARTFYIIEREPLIN | 111 | Q8IUR0 |